HGC Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

HGC Investment Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-75,000	Closed	-$3.02M	–	183
2026 Q1	$3.02M	Buy	+75,000	New	+$1.62M	0.67%	55

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HGC Investment Management's APLS Position: Q2 2026 in Review

HGC Investment Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 75,000 shares — an estimated $3.02M sold.

HGC Investment Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $3.02M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

HGC Investment Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
HGC Investment Management sold 75,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.02M.
HGC Investment Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
HGC Investment Management's Apellis Pharmaceuticals position peaked at $3.02M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on HGC Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.